Published in Pediatrics on October 01, 1980
Maternal and neonatal herpes simplex virus infections. N Engl J Med (2009) 2.85
Rapid detection of herpes simplex virus in clinical specimens with human embryonic lung fibroblast and primary rabbit kidney cell cultures. J Clin Microbiol (1984) 2.52
Oral acyclovir suppression and neurodevelopment after neonatal herpes. N Engl J Med (2011) 2.18
Neonatal herpes simplex infection. Clin Microbiol Rev (2004) 2.06
Comparison of guinea pig embryo cells, rabbit kidney cells, and human embryonic lung fibroblast cell strains for isolation of herpes simplex virus. J Clin Microbiol (1982) 1.97
Delayed acyclovir therapy and death among neonates with herpes simplex virus infection. Pediatrics (2011) 1.63
Early-onset neonatal sepsis. Clin Microbiol Rev (2014) 1.53
Comparison of the efficacy of vidarabine, its carbocyclic analog (cyclaradine), and cyclaradine-5'-methoxyacetate in the treatment of herpes simplex virus type 1 encephalitis in mice. Antimicrob Agents Chemother (1983) 1.32
Herpes simplex virus infections of women and their offspring: implications for a developed society. Proc Natl Acad Sci U S A (1994) 1.14
Clinical use of acyclovir. Br Med J (Clin Res Ed) (1985) 1.10
Antiviral therapy for herpesvirus central nervous system infections: neonatal herpes simplex virus infection, herpes simplex encephalitis, and congenital cytomegalovirus infection. Antiviral Res (2009) 1.09
Antiviral therapy: current concepts and practices. Clin Microbiol Rev (1992) 0.96
Evaluation of a commercial enzyme-linked immunosorbent assay for the detection of herpes simplex virus. J Clin Microbiol (1985) 0.94
Neonatal herpes simplex virus infections: where are we now? Adv Exp Med Biol (2011) 0.93
Guidance on management of asymptomatic neonates born to women with active genital herpes lesions. Pediatrics (2013) 0.91
Neonatal herpes simplex fulminant hepatitis successfully treated with acyclovir. J Clin Neonatol (2012) 0.90
Amplification techniques for detection of herpes simplex virus in neonatal and maternal genital specimens obtained at delivery. J Clin Microbiol (1989) 0.86
The challenge of developing a herpes simplex virus 2 vaccine. Expert Rev Vaccines (2012) 0.85
Imaging findings of neonatal herpes simplex virus type 2 encephalitis. Neuroradiology (2008) 0.84
Frequent genital HSV-2 shedding among women during labor in Soweto, South Africa. Infect Dis Obstet Gynecol (2014) 0.81
Preventing herpes simplex virus in the newborn. Clin Perinatol (2014) 0.80
Chemotherapy for herpes simplex virus infections. West J Med (1985) 0.78
Treatment of herpes simplex virus infections in pediatric patients: current status and future needs. Clin Pharmacol Ther (2010) 0.77
Additive effects of acyclovir and immune transfer in neonatal herpes simplex virus infection in mice. Infect Immun (1983) 0.77
5'-O-D-valyl ara A, a potential prodrug for improving oral bioavailability of the antiviral agent vidarabine. Nucleosides Nucleotides Nucleic Acids (2009) 0.77
Herpes Simplex Virus Infections of the Newborn. Curr Treat Options Neurol (2005) 0.77
Prevention and treatment of experimental herpes simplex virus encephalitis with human immune serum globulin. Antimicrob Agents Chemother (1987) 0.77
Patient satisfaction with care for genital herpes: insights from a global survey. Sex Transm Infect (2004) 0.77
N-Methanocarbathymidine is more effective than acyclovir for treating neonatal herpes simplex virus infection in guinea pigs. Antiviral Res (2011) 0.76
Progressive corneal vascularisation as a previously unreported complication of neonatal herpes simplex infection. Br J Ophthalmol (1994) 0.75
A case of neonatal herpes simplex with pneumonia. Can Med Assoc J (1983) 0.75
Mother-to-Child Transmission of Herpes Simplex Virus. J Pediatric Infect Dis Soc (2014) 0.75
Sexually transmitted diseases in children: herpes simplex virus infection, cytomegalovirus infection, hepatitis B virus infection and molluscum contagiosum. Genitourin Med (1993) 0.75
Treatment of perinatal viral infections to improve neurologic outcomes. Pediatr Res (2016) 0.75
Do antepartum herpes simplex virus cultures predict intrapartum shedding for pregnant women with recurrent disease? Infect Dis Obstet Gynecol (1999) 0.75
Evaluation of prodrugs of 9-beta-D-arabinofuranosyladenine for therapeutic efficacy in the topical treatment of genital herpesvirus infections in guinea pigs. Antimicrob Agents Chemother (1983) 0.75
Pediatrics-epitomes of progress: treatment of disseminated herpes infections in newborns and infants. West J Med (1982) 0.75
Antiviral agents for the control of viral diseases. Bull World Health Organ (1981) 0.75
Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system. J Clin Oncol (2001) 10.20
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma. J Clin Oncol (2001) 9.68
Herpes simplex virus type 2 in the United States, 1976 to 1994. N Engl J Med (1997) 7.59
Mapping of herpes simplex virus-1 neurovirulence to gamma 134.5, a gene nonessential for growth in culture. Science (1990) 6.70
Ampicillin-resistant Haemophilus influenzae type B infection. JAMA (1974) 5.90
The outcome of congenital cytomegalovirus infection in relation to maternal antibody status. N Engl J Med (1992) 5.11
Association of antigenic type of Herpesvirus hominis with site of viral recovery. J Immunol (1967) 5.07
Adenine arabinoside therapy of biopsy-proved herpes simplex encephalitis. National Institute of Allergy and Infectious Diseases collaborative antiviral study. N Engl J Med (1977) 5.02
Case definitions, diagnostic algorithms, and priorities in encephalitis: consensus statement of the international encephalitis consortium. Clin Infect Dis (2013) 4.51
Vidarabine versus acyclovir therapy in herpes simplex encephalitis. N Engl J Med (1986) 4.37
Acyclovir with and without prednisone for the treatment of herpes zoster. A randomized, placebo-controlled trial. The National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. Ann Intern Med (1996) 4.28
Rapid detection of herpes-simplex-virus DNA in cerebrospinal fluid of patients with herpes simplex encephalitis. Lancet (1990) 4.12
Infection with herpes-simplex viruses 1 and 2. 3. N Engl J Med (1973) 3.89
Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA (1988) 3.89
A multifactorial analysis of melanoma. IV. Prognostic factors in 200 melanoma patients with distant metastases (stage III). J Clin Oncol (1983) 3.80
A controlled trial of acyclovir for chickenpox in normal children. N Engl J Med (1991) 3.78
An African HIV-1 sequence from 1959 and implications for the origin of the epidemic. Nature (1998) 3.69
A trial of topical acyclovir in genital herpes simplex virus infections. N Engl J Med (1982) 3.66
Congenital cytomegalovirus infection: The relative importance of primary and recurrent maternal infection. N Engl J Med (1982) 3.66
The natural history of herpes simplex virus infection of mother and newborn. Pediatrics (1980) 3.65
Comparative study of diagnostic procedures for congenital cytomegalovirus infection. Pediatrics (1980) 3.53
Primary cytomegalovirus infection in pregnancy. Incidence, transmission to fetus, and clinical outcome. JAMA (1986) 3.37
Antigenic and biologic differences in herpesvirus hominis. Prog Med Virol (1968) 3.31
A short-term clinical evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriptase. L-697,661 Working Group. N Engl J Med (1993) 2.98
A seroepidemiologic survey of the prevalence of herpes simplex virus type 2 infection in the United States. N Engl J Med (1989) 2.94
A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow's staging methods. Ann Surg (1978) 2.94
Herpesviridae. Definition, provisional nomenclature, and taxonomy. The Herpesvirus Study Group, the International Committee on Taxonomy of Viruses. Intervirology (1981) 2.92
Natural history of neonatal herpes simplex virus infections in the acyclovir era. Pediatrics (2001) 2.91
Infection with herpes-simplex viruses 1 and 2. 1. N Engl J Med (1973) 2.87
Antibodies to Herpesvirus hominis types 1 and 2 in humans. I. Patients with genital herpetic infections. Am J Epidemiol (1970) 2.83
Herpes simplex virus encephalitis: laboratory evaluations and their diagnostic significance. J Infect Dis (1982) 2.70
Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68
A multifactorial analysis of melanoma. II. Prognostic factors in patients with stage I (localized) melanoma. Surgery (1979) 2.65
Typing of Herpesvirus hominis strains by a direct immunofluorescent technique. Proc Soc Exp Biol Med (1969) 2.64
Infection of the newborn with herpesvirus hominis. Adv Pediatr (1970) 2.61
Herpes simplex encephalitis: vidarabine therapy and diagnostic problems. N Engl J Med (1981) 2.56
Detection of cell-dependent cytotoxic antibody to cells infected with herpes simplex virus. Nature (1974) 2.55
Difference between herpes simplex virus type 1 and type 2 neonatal encephalitis in neurological outcome. Lancet (1988) 2.54
Detection of herpes simplex virus type 2-specific antibody with glycoprotein G. J Clin Microbiol (1985) 2.54
Cytology and histopathology of cervical herpes simplex infection. Cancer (1966) 2.52
Different patterns of neurologic involvement with herpes simplex virus types 1 and 2: isolation of herpes simplex virus type 2 from the buffy coat of two adults with meningitis. J Infect Dis (1973) 2.52
NIH conference. Herpes zoster-varicella infections in immunosuppressed patients. Ann Intern Med (1978) 2.52
Antibody-dependent cell-mediated cytotoxicity to target cells infected with type 1 and type 2 herpes simplex virus. J Immunol (1976) 2.49
Identification of a herpes simplex virus 1 glycoprotein gene within a gene cluster dispensable for growth in cell culture. Proc Natl Acad Sci U S A (1987) 2.48
Tumor thickness as a guide to surgical management of clinical stage I melanoma patients. Cancer (1979) 2.41
Perinatal risk associated with maternal genital herpes simplex virus infection. Am J Obstet Gynecol (1971) 2.40
Genital infection with type 2 Herpes virus hominis. A commonly occurring venereal disease. Br J Vener Dis (1969) 2.40
Symptomatic congenital cytomegalovirus infection: neonatal morbidity and mortality. Pediatr Infect Dis J (1992) 2.40
Diseases that mimic herpes simplex encephalitis. Diagnosis, presentation, and outcome. NIAD Collaborative Antiviral Study Group. JAMA (1989) 2.38
Studies on antibody in congenital rubella infections. I. Physicochemical and immunologic investigations of rubella neutralizing antibody. Am J Dis Child (1965) 2.37
Adjuvant therapy of stage III and IV malignant melanoma using granulocyte-macrophage colony-stimulating factor. J Clin Oncol (2000) 2.37
Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics (1980) 2.35
Congenital cytomegalovirus infection. N Engl J Med (1977) 2.35
Relation of pock size on chorioallantoic membrane to antigenic type of herpesvirus hominis. Proc Soc Exp Biol Med (1968) 2.34
Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections. Pediatrics (2001) 2.30
Breast milk and the risk of cytomegalovirus infection. N Engl J Med (1980) 2.27
Herpes simplex virus infection as a risk factor for human immunodeficiency virus infection in heterosexuals. J Infect Dis (1992) 2.25
Maternal cytomegalovirus excretion and perinatal infection. N Engl J Med (1973) 2.21
Human monocyte-macrophage-mediated antibody-dependent cytotoxicity to herpes simplex virus-infected cells. J Immunol (1977) 2.21
Improved staging of node-negative patients with intermediate to thick melanomas (>1 mm) with the use of lymphatic mapping and sentinel lymph node biopsy. Ann Surg Oncol (2001) 2.19
Inapparent congenital cytomegalovirus infection with elevated cord IgM levels. Casual relation with auditory and mental deficiency. N Engl J Med (1974) 2.16
Antibodies to Herpesvirus hominis types 1 and 2 in humans. II. Women with cervical cancer. Am J Epidemiol (1970) 2.15
A community surveillance system of infectious diseases in the greater Atlanta area. Am J Public Health Nations Health (1966) 2.11
Inhibitory effect of heparin on herpes simplex virus. J Bacteriol (1964) 2.11
Gamma-M-fluorescent treponemal antibody in the diagnosis of congenital syphilis. N Engl J Med (1969) 2.10
Genital herpetic infection. Association with cervical dysplasia and carcinoma. Cancer (1969) 2.10
A comparison of prognostic factors and surgical results in 1,786 patients with localized (stage I) melanoma treated in Alabama, USA, and New South Wales, Australia. Ann Surg (1982) 2.09
Adenine arabinoside therapy of herpes zoster in the immunosuppressed. NIAID collaborative antiviral study. N Engl J Med (1976) 2.09
A correlative immunologic, microbiologic and clinical approach to the diagnosis of acute and chronic infections in newborn infants. N Engl J Med (1967) 2.09
A multifactorial analysis of melanoma: III. Prognostic factors in melanoma patients with lymph node metastases (stage II). Ann Surg (1981) 2.09
Congenital cytomegalovirus infection: diagnostic and prognostic significance of the detection of specific immunoglobulin M antibodies in cord serum. Pediatrics (1982) 2.07
Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06
Engineered herpes simplex virus expressing IL-12 in the treatment of experimental murine brain tumors. Proc Natl Acad Sci U S A (2000) 1.99
Comparative serial virologic and serologic studies of symptomatic and subclinical congenitally and natally acquired cytomegalovirus infections. J Infect Dis (1975) 1.97
Genital herpes simplex infection. Virologic and cytologic studies. Obstet Gynecol (1967) 1.95
Acyclovir treatment of varicella in otherwise healthy adolescents. The Collaborative Acyclovir Varicella Study Group. J Pediatr (1992) 1.94
High-level viremia in adults and children infected with human immunodeficiency virus: relation to disease stage and CD4+ lymphocyte levels. J Infect Dis (1991) 1.94
Specificity of porcine pancreatic elastase, human leukocyte elastase and cathepsin G. Inhibition with peptide chloromethyl ketones. Biochim Biophys Acta (1977) 1.84
Herpes simplex encephalitis. Clinical Assessment. JAMA (1982) 1.83